379 related articles for article (PubMed ID: 19883617)
1. FXR acetylation is normally dynamically regulated by p300 and SIRT1 but constitutively elevated in metabolic disease states.
Kemper JK; Xiao Z; Ponugoti B; Miao J; Fang S; Kanamaluru D; Tsang S; Wu SY; Chiang CM; Veenstra TD
Cell Metab; 2009 Nov; 10(5):392-404. PubMed ID: 19883617
[TBL] [Abstract][Full Text] [Related]
2. The p300 acetylase is critical for ligand-activated farnesoid X receptor (FXR) induction of SHP.
Fang S; Tsang S; Jones R; Ponugoti B; Yoon H; Wu SY; Chiang CM; Willson TM; Kemper JK
J Biol Chem; 2008 Dec; 283(50):35086-95. PubMed ID: 18842595
[TBL] [Abstract][Full Text] [Related]
3. Acetylation of lysine 109 modulates pregnane X receptor DNA binding and transcriptional activity.
Pasquel D; Doricakova A; Li H; Kortagere S; Krasowski MD; Biswas A; Walton WG; Redinbo MR; Dvorak Z; Mani S
Biochim Biophys Acta; 2016 Sep; 1859(9):1155-1169. PubMed ID: 26855179
[TBL] [Abstract][Full Text] [Related]
4. A pathway involving farnesoid X receptor and small heterodimer partner positively regulates hepatic sirtuin 1 levels via microRNA-34a inhibition.
Lee J; Padhye A; Sharma A; Song G; Miao J; Mo YY; Wang L; Kemper JK
J Biol Chem; 2010 Apr; 285(17):12604-11. PubMed ID: 20185821
[TBL] [Abstract][Full Text] [Related]
5. Bile salt excretory pump: biology and pathobiology.
Suchy FJ; Ananthanarayanan M
J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S10-6. PubMed ID: 16819395
[TBL] [Abstract][Full Text] [Related]
6. SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism.
Ponugoti B; Kim DH; Xiao Z; Smith Z; Miao J; Zang M; Wu SY; Chiang CM; Veenstra TD; Kemper JK
J Biol Chem; 2010 Oct; 285(44):33959-70. PubMed ID: 20817729
[TBL] [Abstract][Full Text] [Related]
7. Ligand binding and heterodimerization with retinoid X receptor α (RXRα) induce farnesoid X receptor (FXR) conformational changes affecting coactivator binding.
Wang N; Zou Q; Xu J; Zhang J; Liu J
J Biol Chem; 2018 Nov; 293(47):18180-18191. PubMed ID: 30275017
[TBL] [Abstract][Full Text] [Related]
8. Glucagon-induced acetylation of Foxa2 regulates hepatic lipid metabolism.
von Meyenn F; Porstmann T; Gasser E; Selevsek N; Schmidt A; Aebersold R; Stoffel M
Cell Metab; 2013 Mar; 17(3):436-47. PubMed ID: 23416070
[TBL] [Abstract][Full Text] [Related]
9. A dysregulated acetyl/SUMO switch of FXR promotes hepatic inflammation in obesity.
Kim DH; Xiao Z; Kwon S; Sun X; Ryerson D; Tkac D; Ma P; Wu SY; Chiang CM; Zhou E; Xu HE; Palvimo JJ; Chen LF; Kemper B; Kemper JK
EMBO J; 2015 Jan; 34(2):184-99. PubMed ID: 25425577
[TBL] [Abstract][Full Text] [Related]
10. A fasting inducible switch modulates gluconeogenesis via activator/coactivator exchange.
Liu Y; Dentin R; Chen D; Hedrick S; Ravnskjaer K; Schenk S; Milne J; Meyers DJ; Cole P; Yates J; Olefsky J; Guarente L; Montminy M
Nature; 2008 Nov; 456(7219):269-73. PubMed ID: 18849969
[TBL] [Abstract][Full Text] [Related]
11. Involvement of mammalian sirtuin 1 in the action of ethanol in the liver.
You M; Liang X; Ajmo JM; Ness GC
Am J Physiol Gastrointest Liver Physiol; 2008 Apr; 294(4):G892-8. PubMed ID: 18239056
[TBL] [Abstract][Full Text] [Related]
12. Acetylation of FOXM1 is essential for its transactivation and tumor growth stimulation.
Lv C; Zhao G; Sun X; Wang P; Xie N; Luo J; Tong T
Oncotarget; 2016 Sep; 7(37):60366-60382. PubMed ID: 27542221
[TBL] [Abstract][Full Text] [Related]
13. The type III histone deacetylase Sirt1 protein suppresses p300-mediated histone H3 lysine 56 acetylation at Bclaf1 promoter to inhibit T cell activation.
Kong S; Kim SJ; Sandal B; Lee SM; Gao B; Zhang DD; Fang D
J Biol Chem; 2011 May; 286(19):16967-75. PubMed ID: 21454709
[TBL] [Abstract][Full Text] [Related]
14. An acetylation/deacetylation-SUMOylation switch through a phylogenetically conserved psiKXEP motif in the tumor suppressor HIC1 regulates transcriptional repression activity.
Stankovic-Valentin N; Deltour S; Seeler J; Pinte S; Vergoten G; Guérardel C; Dejean A; Leprince D
Mol Cell Biol; 2007 Apr; 27(7):2661-75. PubMed ID: 17283066
[TBL] [Abstract][Full Text] [Related]
15. A maternal high-fat diet modulates fetal SIRT1 histone and protein deacetylase activity in nonhuman primates.
Suter MA; Chen A; Burdine MS; Choudhury M; Harris RA; Lane RH; Friedman JE; Grove KL; Tackett AJ; Aagaard KM
FASEB J; 2012 Dec; 26(12):5106-14. PubMed ID: 22982377
[TBL] [Abstract][Full Text] [Related]
16. SIRT1 is involved in glucocorticoid-mediated control of uncoupling protein-3 gene transcription.
Amat R; Solanes G; Giralt M; Villarroya F
J Biol Chem; 2007 Nov; 282(47):34066-76. PubMed ID: 17884810
[TBL] [Abstract][Full Text] [Related]
17. An acetylation switch modulates the transcriptional activity of estrogen-related receptor alpha.
Wilson BJ; Tremblay AM; Deblois G; Sylvain-Drolet G; Giguère V
Mol Endocrinol; 2010 Jul; 24(7):1349-58. PubMed ID: 20484414
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of SRT1720 via the HNF1α/FXR signalling pathway and anti-inflammatory mechanisms in mice with estrogen-induced cholestatic liver injury.
Yu L; Liu X; Li X; Yuan Z; Yang H; Zhang L; Jiang Z
Toxicol Lett; 2016 Dec; 264():1-11. PubMed ID: 27818225
[TBL] [Abstract][Full Text] [Related]
19. Hepatic deletion of SIRT1 decreases hepatocyte nuclear factor 1α/farnesoid X receptor signaling and induces formation of cholesterol gallstones in mice.
Purushotham A; Xu Q; Lu J; Foley JF; Yan X; Kim DH; Kemper JK; Li X
Mol Cell Biol; 2012 Apr; 32(7):1226-36. PubMed ID: 22290433
[TBL] [Abstract][Full Text] [Related]
20. Metformin suppresses hepatic gluconeogenesis through induction of SIRT1 and GCN5.
Caton PW; Nayuni NK; Kieswich J; Khan NQ; Yaqoob MM; Corder R
J Endocrinol; 2010 Apr; 205(1):97-106. PubMed ID: 20093281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
